Frontiers in public health · 2026
Effect of Baduanjin exercise on sarcopenia in older adult patients: a multicenter, randomized controlled trial.
СтатьяМногоцентровое исследованиеРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Luruihui Li, Jing Xiao, Yuan Tian, Wenming Liang, Tianyang Tan, Yuxuan Ji, Bingyan Cao, Hanzhi Zhang, Danqiang An, Yufan Zhang, Peng Gao, Yuzhe Wang, Zhuying Lin
Аннотация
BACKGROUND: Sarcopenia is an age-related syndrome characterized by muscle loss and reduced muscle strength, with a high incidence rate, significantly increasing the risk of falls, fractures, and death. Baduanjin, a traditional Chinese exercise, compared with traditional rehabilitation programs, has low intensity, high safety and strong interest, and is particularly suitable for patients who cannot tolerate high-intensity exercise. This study will evaluate the therapeutic effect of Baduanjin on sarcopenia.
METHOD/DESIGN: This trial is a multicenter randomized controlled trial that will recruit 200 participants,and is randomized (1: 1) the subjects to the intervention group (Baduanjin + health education + dietary guidance, BHD) and the control group (health education + dietary guidance, HD). After enrollment, health lectures were given to all subjects. The intervention group received 12 weeks of Baduanjin intervention, with each class lasting 70 min, once a week, and provide online guidance for home workouts four times a week, while the control group maintained their original exercise habits. Health education and dietary guidance were also provided. Observation indicators will be tested before the trial begins and during the follow-up period after the intervention ends.
DISCUSSION: This trial is a randomized controlled trial that will evaluate the intervention effect of Baduanjin on sarcopenia. According to the study of this trial, it will provide evidence for Baduanjin to improve sarcopenia.
CLINICAL TRIAL REGISTRATION: ITMCTR2024000887.
METHOD/DESIGN: This trial is a multicenter randomized controlled trial that will recruit 200 participants,and is randomized (1: 1) the subjects to the intervention group (Baduanjin + health education + dietary guidance, BHD) and the control group (health education + dietary guidance, HD). After enrollment, health lectures were given to all subjects. The intervention group received 12 weeks of Baduanjin intervention, with each class lasting 70 min, once a week, and provide online guidance for home workouts four times a week, while the control group maintained their original exercise habits. Health education and dietary guidance were also provided. Observation indicators will be tested before the trial begins and during the follow-up period after the intervention ends.
DISCUSSION: This trial is a randomized controlled trial that will evaluate the intervention effect of Baduanjin on sarcopenia. According to the study of this trial, it will provide evidence for Baduanjin to improve sarcopenia.
CLINICAL TRIAL REGISTRATION: ITMCTR2024000887.